115 related articles for article (PubMed ID: 38549990)
1. Retracted: Establishment and Validation of an MTORC1 Signaling-Related Gene Signature to Predict Overall Survival in Patients with Hepatocellular Carcinoma.
International BR
Biomed Res Int; 2024; 2024():9851737. PubMed ID: 38549990
[TBL] [Abstract][Full Text] [Related]
2. Retracted: Development and Validation of a Novel Mitophagy-Related Gene Prognostic Signature for Hepatocellular Carcinoma Based on Immunoscore Classification of Tumor.
Oncology JO
J Oncol; 2023; 2023():9803262. PubMed ID: 37869587
[TBL] [Abstract][Full Text] [Related]
3. Retracted: Development of a Bile Acid-Related Gene Signature for Predicting Survival in Patients with Hepatocellular Carcinoma.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9865740. PubMed ID: 38094394
[TBL] [Abstract][Full Text] [Related]
4. Retracted: New Pyroptosis-Associated Gene Signature for Overall Survival Forecast among Patients Suffering from Hepatocellular Carcinoma.
Healthcare Engineering JO
J Healthc Eng; 2023; 2023():9809725. PubMed ID: 37621615
[TBL] [Abstract][Full Text] [Related]
5. Establishment and Validation of an MTORC1 Signaling-Related Gene Signature to Predict Overall Survival in Patients with Hepatocellular Carcinoma.
Yao Z; Wen S; Luo J; Hao W; Liang W; Chen Y
Biomed Res Int; 2021; 2021():6299472. PubMed ID: 34853791
[TBL] [Abstract][Full Text] [Related]
6. Retracted: Establishment and External Validation of a Hypoxia-Derived Gene Signature for Robustly Predicting Prognosis and Therapeutic Responses in Glioblastoma Multiforme.
International BR
Biomed Res Int; 2024; 2024():9756795. PubMed ID: 38550039
[TBL] [Abstract][Full Text] [Related]
7. Retracted: Prediction of Hepatocellular Carcinoma Prognosis and Immune Cell Infiltration Using Gene Signature Associated with Inflammatory Response.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9759467. PubMed ID: 38094384
[TBL] [Abstract][Full Text] [Related]
8. Retracted: Ferroptosis-Related lncRNA for the Establishment of Novel Prognostic Signature and Therapeutic Response Prediction to Endometrial Carcinoma.
International BR
Biomed Res Int; 2022; 2022():9829634. PubMed ID: 36605105
[TBL] [Abstract][Full Text] [Related]
9. Retracted: Identification and Validation of an Inflammatory Response-Related Polygenic Risk Score as a Prognostic Marker in Hepatocellular Carcinoma.
Markers D
Dis Markers; 2023; 2023():9809678. PubMed ID: 37538093
[TBL] [Abstract][Full Text] [Related]
10. Retracted: Identification of a 5-Nutrient Stress-Sensitive Gene Signature to Predict Survival for Colorectal Cancer.
International BR
Biomed Res Int; 2024; 2024():9823079. PubMed ID: 38550151
[TBL] [Abstract][Full Text] [Related]
11. Retracted: Identification and Validation of Key Genes in Hepatocellular Carcinoma by Bioinformatics Analysis.
International BR
Biomed Res Int; 2024; 2024():9784513. PubMed ID: 38230025
[TBL] [Abstract][Full Text] [Related]
12. Retracted: A Novel Immune-Associated Gene Signature for Overall Survival Prediction in Patients with Oral Squamous Cell Carcinoma.
And Alternative Medicine EC
Evid Based Complement Alternat Med; 2023; 2023():9875478. PubMed ID: 38125198
[TBL] [Abstract][Full Text] [Related]
13. A novel hepatocellular carcinoma-specific mTORC1-related signature for anticipating prognosis and immunotherapy.
Chen E; Mo Y; Yi J; Liu J; Luo T; Li Z; Lin Z; Hu Y; Zou Z; Liu J
Aging (Albany NY); 2023 Aug; 15(16):7933-7955. PubMed ID: 37589508
[TBL] [Abstract][Full Text] [Related]
14. Retracted: Clinical Value of PPM1G Gene in Survival Prognosis and Immune Infiltration of Hepatocellular Carcinoma.
And Biomechanics AB
Appl Bionics Biomech; 2023; 2023():9862929. PubMed ID: 37946818
[TBL] [Abstract][Full Text] [Related]
15. Retracted: circSOX4 Enhances Hepatocellular Carcinoma Progression via miR-218-5p/YY1 Signaling.
International BR
Biomed Res Int; 2023; 2023():9896369. PubMed ID: 38075344
[TBL] [Abstract][Full Text] [Related]
16. Retracted: The Relationship between Ultrasonographic Features of Hepatocellular Carcinoma and the Severity of Hepatocellular Carcinoma and the Expression of PTEN and Tg737.
Healthcare Engineering JO
J Healthc Eng; 2023; 2023():9848563. PubMed ID: 37829384
[TBL] [Abstract][Full Text] [Related]
17. Retracted: Identification of a Ferroptosis-Related Prognostic Signature in Sepsis via Bioinformatics Analyses and Experiment Validation.
International BR
Biomed Res Int; 2024; 2024():9785480. PubMed ID: 38550060
[TBL] [Abstract][Full Text] [Related]
18. Retracted: Identification of Oxidative Stress-Associated Molecular Subtypes and Signature for Predicting Survival Outcome of Cervical Squamous Cell Carcinoma.
Longevity OMAC
Oxid Med Cell Longev; 2023; 2023():9795318. PubMed ID: 37565171
[TBL] [Abstract][Full Text] [Related]
19. Retracted: Comparison of 10-Year Survival Outcomes for Early Single Hepatocellular Carcinoma following Different Treatments.
International BR
Biomed Res Int; 2023; 2023():9827803. PubMed ID: 37475816
[TBL] [Abstract][Full Text] [Related]
20. Retracted: circRNA LDLRAD3 Enhances the Malignant Behaviors of NSCLC Cells via the miR-20a-5p-SLC7A5 Axis Activating the mTORC1 Signaling Pathway.
Healthcare Engineering JO
J Healthc Eng; 2023; 2023():9756529. PubMed ID: 37886338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
